title: Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells.
abstract: Arsenic is known to produce inhibition as well as induction of immune cells proliferative responses depending on the doses as one of its mechanisms of immunotoxicity. Here we evaluate the effect of arsenic exposure on the activation of splenic mononuclear cells (SMC) in male CD57BL6N mice. Intra-gastric exposure to arsenic (as sodium arsenite) for 30 days (1, 0.1, or 0.01 mg/kg/day), reduced the proportion of CD4+ cells and the CD4+/CD8+ ratio in the spleen, increasing the proportion of CD11b+ cells. Arsenic exposure did not modify the proportion of B cells. SMC showed an increased level of phosphorylation of lck and fyn kinases (first kinases associated to TCR complex when activated). Although normal levels of apoptosis were observed on freshly isolated SMC, an increase in apoptotic cells related with the increase in phosphorylation of lck and fyn was observed when SMC were activated with Concanavalin-A (Con-A). Arsenic exposure reduced the proliferative response of SMC to Con-A, and also reduced secretion of IL-2, IL-6, IL-12 and IFNgamma. No effect was observed on IL-4, and IL-10 secretion. The same effects were observed when SMC of exposed animals were activated with anti-CD3/CD28 antibodies for 24 h, but these effects were transitory since a recovery, up to control levels or even higher, were observed after 72 h of stimulation. This study demonstrates that repeated and prolonged exposure to arsenic alters cell populations and produces functional changes depending on the specific activation pathway, and could be related with the phosphorylation status of lck and fyn kinases.
authors.affiliation: Sección Externa de Toxicología, CINVESTAV, Av. IPN 2508, San Pedro Zacatenco, México D. F., 07360, Mexico.
authors.forename: Gerson A
authors.initials: GA
authors.lastname: Soto-Peña
authors.forename: Libia
authors.initials: L
authors.lastname: Vega
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001151:Arsenic / Q000494:pharmacology*; D001835:Body Weight / Q000187:drug effects; D018106:CD28 Antigens / Q000378:metabolism; D017252:CD3 Complex / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival; D016207:Cytokines / Q000096:biosynthesis; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck) / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009000:Monocytes / Q000187:drug effects; D009336:Necrosis; D010766:Phosphorylation; D051076:Proto-Oncogene Proteins c-fyn / Q000096:biosynthesis* / Q000235:genetics; D011948:Receptors, Antigen, T-Cell / Q000187:drug effects*; D015398:Signal Transduction / Q000187:drug effects*; D013154:Spleen / Q000166:cytology* / Q000187:drug effects; D013778:Tetrazolium Salts; D013844:Thiazoles
chemical_list: D018106:CD28 Antigens; D017252:CD3 Complex; D016207:Cytokines; D011948:Receptors, Antigen, T-Cell; D013778:Tetrazolium Salts; D013844:Thiazoles; C494960:Fyn protein, mouse; D019860:Lymphocyte Specific Protein Tyrosine Kinase p56(lck); D051076:Proto-Oncogene Proteins c-fyn; C022616:thiazolyl blue; D001151:Arsenic